Your trusted health, nutrition, and personalized lifestyle medicine resource

SPMs and Vulvar Disease


In this interview, Megan Falsetta, PhD addresses the prevalence and characteristics of patients with vulvar disease. She discusses the role of inflammation in chronic vulvar pain. Dr. Falsetta highlights research findings indicating that exogenous specialized pro-resolving mediators (SPMs) have shown promising therapeutic effects in resolving pain in animal models. She expresses hope that SPMs might eventually help patients avoid invasive surgeries. Her team is planning to commence human trials soon. Dr. Falsetta concludes by discussing the role of Omega-3 supplements and nutrition in vulvar disease.

Megan Falsetta, PhD, is an Assistant Professor of Obstetrics and Gynecology, Pharmacology and Physiology at University of Rochester Medical Center.

From the 17th International Conference on Bioactive Lipids in Cancer, Inflammation and Related Diseases, October 2022 in New Orleans, Louisiana

Related Content

Metagenics Institute is a trusted, peer-to-peer, evidence-based educational resource for nutrition and personalized medicine.
At Metagenics Institute, we translate credible research with scientific integrity into innovative and actionable clinical
decision-making. Metagenics Institute supports a diverse practitioner base to optimize patient outcomes by shifting existing paradigms in healthcare. Our mission is to transform healthcare by inspiring and educating practitioners, and their patients, about personalized lifestyle medicine.

Sponsored by
© 2024 Metagenics Institute. All Rights Reserved